Sameer Salunkhe, Ph.D.

1. Mittra I, Samant U, Sharma S, Raghuram GV, Saha T, Tidke P, Pancholi N, Gupta D, Prasannan P, Gaikwad A, Salunkhe S. Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation. Cell Death Discovery. 2017;3(1):1-14.

1. Godbole M, Togar T, Patel K, Dharavath B, Yadav N, Janjuha S, Gardi N, Tiwary K, Terwadkar P, Desai S, Salunkhe S. Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1–NDRG1 axis in both PR-positive and-negative breast cancer cells. Journal of Biological Chemistry. 2018;293(50):19263-76.

1. Rajendra J, Datta KK, Farooqee SBUD, Thorat R, Kumar K, Gardi N, Kaur E, Nair J, Salunkhe S, Patkar K. Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells. Oncotarget. 2018;9(45):27667.

1. Salunkhe S, Mishra SV, Nair J, Ghosh S, Choudhary N, Kaur E, Shah S, Patkar K, Anand D, Khattry N. Inhibition of novel GCN5–ATM axis restricts the onset of acquired drug resistance in leukemia. International journal of cancer. 2018;142(10):2175-85.

1. Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B. ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early-stage gallbladder cancer. International journal of cancer. 2019;144(8):2008-19.

1. Kaur E, Goda JS, Ghorai A, Salunkhe S, Shetty P, Moiyadi AV, Sridhar E, Mahajan A, Jalali R, Dutt S. Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome-a short report. Cellular oncology. 2019;42:107-16.

1. Kaur E, Nair J, Ghorai A, Mishra SV, Achareker A, Ketkar M, Sarkar D, Salunkhe S, Rajendra J, Gardi N. Inhibition of SETMAR–H3K36me2–NHEJ repair axis in residual disease cells prevents glioblastoma recurrence. Neuro-oncology. 2020;22(12):1785-96.

1. Salunkhe S, Chandran N, Chandrani P, Dutt A, Dutt S. CytoPred: 7-gene pair metric for AML cytogenetic risk prediction. Briefings in Bioinformatics. 2020;21(1):348-54.

1. Salunkhe S, Mishra SV, Ghorai A, Hole A, Chandrani P, Dutt A, Chilakapati M, Dutt S. Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics. Biochimica et Biophysica Acta (BBA)-Bioenergetics. 2020;1861(12):148300.

1. Salunkhe S, Mishra SV, Nair J, Shah S, Gardi N, Thorat R, Sarkar D, Rajendra J, Kaur E, Dutt S. Nuclear localization of p65 reverses therapy-induced senescence. Journal of cell science. 2021;134(6):jcs253203.

1. Xue C, Salunkhe SJ, Tomimatsu N, Kawale AS, Kwon Y, Burma S, Sung P, Greene EC. Bloom helicase mediates formation of large single–stranded DNA loops during DNA end processing. Nature communications. 2022;13(1):2248.

1. Salunkhe S, Daley JM, Kaur H, Tomimatsu N, Xue C, Raina VB, Jasper AM, Rogers CM, Li W, Zhou S. Promotion of DNA end resection by BRCA1–BARD1 in homologous recombination. Nature. 2024:1-10.

Original Peer-Reviewed Articles in Press or in Revision for Press: 

1. Cody M. Rogers, Hardeep Kaur, Michelle L. Swift, Shuo Zhou, Ajinkya S. Kawale, Shahrez Syed, Korilynn G. Kelly, Angela M. Jasper, Salunkhe, S., et al. (2024) CTC1-STN1-TEN1 Restricts DNA End Resection in Homologous Recombination. (revision in Science)